1st Mar 2021 10:14
4D Pharma PLC - Leeds-based live biotherapeutic products developer - Appoints John Beck, most recently chief financial officer at Ritter Pharmaceuticals, as its own CFO. Beck was senior vice president of Finance and CFO of Ritter from May 2018 to May 2020, overseeing its merger with Qualigen Therapeutics Inc, Before that, Beck was executive manager and chief executive at Wellspring Water Technologies LLC and CEO of West Tech Medical LLC.
Duncan Peyton, CEO of 4D Pharma, says: "John will be an important addition to 4D pharma's management team at such a pivotal time, as the company prepares to close our SPAC merger and begin trading on NASDAQ. His deep experience and financial expertise as a CFO of several publicly traded life sciences companies will be critical as we further grow our company and global footprint."
Current stock price: 132.50 pence
Year-to-date change: up 2.7%
By Anna Farley; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
DDDD.L